IBDEI06Z ; ; 01-AUG-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;AUG 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16928,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16928,1,3,0)
 ;;=3^DM Type 1 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,16928,1,4,0)
 ;;=4^E10.638
 ;;^UTILITY(U,$J,358.3,16928,2)
 ;;=^5002620
 ;;^UTILITY(U,$J,358.3,16929,0)
 ;;=E10.641^^56^673^15
 ;;^UTILITY(U,$J,358.3,16929,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16929,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,16929,1,4,0)
 ;;=4^E10.641
 ;;^UTILITY(U,$J,358.3,16929,2)
 ;;=^5002621
 ;;^UTILITY(U,$J,358.3,16930,0)
 ;;=E10.649^^56^673^16
 ;;^UTILITY(U,$J,358.3,16930,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16930,1,3,0)
 ;;=3^DM Type 1 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,16930,1,4,0)
 ;;=4^E10.649
 ;;^UTILITY(U,$J,358.3,16930,2)
 ;;=^5002622
 ;;^UTILITY(U,$J,358.3,16931,0)
 ;;=E10.65^^56^673^14
 ;;^UTILITY(U,$J,358.3,16931,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16931,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,16931,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,16931,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,16932,0)
 ;;=E10.69^^56^673^29
 ;;^UTILITY(U,$J,358.3,16932,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16932,1,3,0)
 ;;=3^DM Type 1 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,16932,1,4,0)
 ;;=4^E10.69
 ;;^UTILITY(U,$J,358.3,16932,2)
 ;;=^5002624
 ;;^UTILITY(U,$J,358.3,16933,0)
 ;;=E10.8^^56^673^33
 ;;^UTILITY(U,$J,358.3,16933,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16933,1,3,0)
 ;;=3^DM Type 1 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,16933,1,4,0)
 ;;=4^E10.8
 ;;^UTILITY(U,$J,358.3,16933,2)
 ;;=^5002625
 ;;^UTILITY(U,$J,358.3,16934,0)
 ;;=E10.9^^56^673^34
 ;;^UTILITY(U,$J,358.3,16934,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16934,1,3,0)
 ;;=3^DM Type 1 w/o Compl
 ;;^UTILITY(U,$J,358.3,16934,1,4,0)
 ;;=4^E10.9
 ;;^UTILITY(U,$J,358.3,16934,2)
 ;;=^5002626
 ;;^UTILITY(U,$J,358.3,16935,0)
 ;;=E10.620^^56^673^5
 ;;^UTILITY(U,$J,358.3,16935,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16935,1,3,0)
 ;;=3^DM Type 1 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,16935,1,4,0)
 ;;=4^E10.620
 ;;^UTILITY(U,$J,358.3,16935,2)
 ;;=^5002615
 ;;^UTILITY(U,$J,358.3,16936,0)
 ;;=E10.36^^56^673^4
 ;;^UTILITY(U,$J,358.3,16936,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16936,1,3,0)
 ;;=3^DM Type 1 w/ Diab Cataract
 ;;^UTILITY(U,$J,358.3,16936,1,4,0)
 ;;=4^E10.36
 ;;^UTILITY(U,$J,358.3,16936,2)
 ;;=^5002602
 ;;^UTILITY(U,$J,358.3,16937,0)
 ;;=E10.621^^56^673^6
 ;;^UTILITY(U,$J,358.3,16937,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16937,1,3,0)
 ;;=3^DM Type 1 w/ Diab Foot Ulcer
 ;;^UTILITY(U,$J,358.3,16937,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,16937,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,16938,0)
 ;;=E10.622^^56^673^28
 ;;^UTILITY(U,$J,358.3,16938,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16938,1,3,0)
 ;;=3^DM Type 1 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,16938,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,16938,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,16939,0)
 ;;=E10.51^^56^673^32
 ;;^UTILITY(U,$J,358.3,16939,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16939,1,3,0)
 ;;=3^DM Type 1 w/ Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,16939,1,4,0)
 ;;=4^E10.51
 ;;^UTILITY(U,$J,358.3,16939,2)
 ;;=^5002610
 ;;^UTILITY(U,$J,358.3,16940,0)
 ;;=E10.52^^56^673^31
 ;;^UTILITY(U,$J,358.3,16940,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16940,1,3,0)
 ;;=3^DM Type 1 w/ Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,16940,1,4,0)
 ;;=4^E10.52
 ;;^UTILITY(U,$J,358.3,16940,2)
 ;;=^5002611
 ;;^UTILITY(U,$J,358.3,16941,0)
 ;;=E11.00^^56^674^19
 ;;^UTILITY(U,$J,358.3,16941,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16941,1,3,0)
 ;;=3^DM Type 2 w/ Hyperosmolarity w/o NKHHC
 ;;^UTILITY(U,$J,358.3,16941,1,4,0)
 ;;=4^E11.00
 ;;^UTILITY(U,$J,358.3,16941,2)
 ;;=^5002627
 ;;^UTILITY(U,$J,358.3,16942,0)
 ;;=E11.01^^56^674^18
 ;;^UTILITY(U,$J,358.3,16942,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16942,1,3,0)
 ;;=3^DM Type 2 w/ Hyperosmolarity w/ Coma
 ;;^UTILITY(U,$J,358.3,16942,1,4,0)
 ;;=4^E11.01
 ;;^UTILITY(U,$J,358.3,16942,2)
 ;;=^5002628
 ;;^UTILITY(U,$J,358.3,16943,0)
 ;;=E11.21^^56^674^7
 ;;^UTILITY(U,$J,358.3,16943,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16943,1,3,0)
 ;;=3^DM Type 2 w/ Diab Nephropathy
 ;;^UTILITY(U,$J,358.3,16943,1,4,0)
 ;;=4^E11.21
 ;;^UTILITY(U,$J,358.3,16943,2)
 ;;=^5002629
 ;;^UTILITY(U,$J,358.3,16944,0)
 ;;=E11.22^^56^674^3
 ;;^UTILITY(U,$J,358.3,16944,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16944,1,3,0)
 ;;=3^DM Type 2 w/ Diab CKD
 ;;^UTILITY(U,$J,358.3,16944,1,4,0)
 ;;=4^E11.22
 ;;^UTILITY(U,$J,358.3,16944,2)
 ;;=^5002630
 ;;^UTILITY(U,$J,358.3,16945,0)
 ;;=E11.39^^56^674^28
 ;;^UTILITY(U,$J,358.3,16945,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16945,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Ophth Compl
 ;;^UTILITY(U,$J,358.3,16945,1,4,0)
 ;;=4^E11.39
 ;;^UTILITY(U,$J,358.3,16945,2)
 ;;=^5002643
 ;;^UTILITY(U,$J,358.3,16946,0)
 ;;=E11.41^^56^674^6
 ;;^UTILITY(U,$J,358.3,16946,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16946,1,3,0)
 ;;=3^DM Type 2 w/ Diab Mononeuropathy
 ;;^UTILITY(U,$J,358.3,16946,1,4,0)
 ;;=4^E11.41
 ;;^UTILITY(U,$J,358.3,16946,2)
 ;;=^5002645
 ;;^UTILITY(U,$J,358.3,16947,0)
 ;;=E11.42^^56^674^13
 ;;^UTILITY(U,$J,358.3,16947,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16947,1,3,0)
 ;;=3^DM Type 2 w/ Diab Polyneuropathy
 ;;^UTILITY(U,$J,358.3,16947,1,4,0)
 ;;=4^E11.42
 ;;^UTILITY(U,$J,358.3,16947,2)
 ;;=^5002646
 ;;^UTILITY(U,$J,358.3,16948,0)
 ;;=E11.43^^56^674^2
 ;;^UTILITY(U,$J,358.3,16948,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16948,1,3,0)
 ;;=3^DM Type 2 w/ Diab Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,16948,1,4,0)
 ;;=4^E11.43
 ;;^UTILITY(U,$J,358.3,16948,2)
 ;;=^5002647
 ;;^UTILITY(U,$J,358.3,16949,0)
 ;;=E11.44^^56^674^1
 ;;^UTILITY(U,$J,358.3,16949,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16949,1,3,0)
 ;;=3^DM Type 2 w/ Diab Amyotrophy
 ;;^UTILITY(U,$J,358.3,16949,1,4,0)
 ;;=4^E11.44
 ;;^UTILITY(U,$J,358.3,16949,2)
 ;;=^5002648
 ;;^UTILITY(U,$J,358.3,16950,0)
 ;;=E11.49^^56^674^8
 ;;^UTILITY(U,$J,358.3,16950,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16950,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neurological Compl
 ;;^UTILITY(U,$J,358.3,16950,1,4,0)
 ;;=4^E11.49
 ;;^UTILITY(U,$J,358.3,16950,2)
 ;;=^5002649
 ;;^UTILITY(U,$J,358.3,16951,0)
 ;;=E11.59^^56^674^25
 ;;^UTILITY(U,$J,358.3,16951,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16951,1,3,0)
 ;;=3^DM Type 2 w/ Oth Circulatory Compl
 ;;^UTILITY(U,$J,358.3,16951,1,4,0)
 ;;=4^E11.59
 ;;^UTILITY(U,$J,358.3,16951,2)
 ;;=^5002652
 ;;^UTILITY(U,$J,358.3,16952,0)
 ;;=E11.610^^56^674^9
 ;;^UTILITY(U,$J,358.3,16952,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16952,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathic Arthropathy
 ;;^UTILITY(U,$J,358.3,16952,1,4,0)
 ;;=4^E11.610
 ;;^UTILITY(U,$J,358.3,16952,2)
 ;;=^5002653
 ;;^UTILITY(U,$J,358.3,16953,0)
 ;;=E11.618^^56^674^26
 ;;^UTILITY(U,$J,358.3,16953,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16953,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Arthropathy
 ;;^UTILITY(U,$J,358.3,16953,1,4,0)
 ;;=4^E11.618
 ;;^UTILITY(U,$J,358.3,16953,2)
 ;;=^5002654
 ;;^UTILITY(U,$J,358.3,16954,0)
 ;;=E11.621^^56^674^16
 ;;^UTILITY(U,$J,358.3,16954,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16954,1,3,0)
 ;;=3^DM Type 2 w/ Foot Ulcer
 ;;^UTILITY(U,$J,358.3,16954,1,4,0)
 ;;=4^E11.621
 ;;^UTILITY(U,$J,358.3,16954,2)
 ;;=^5002656
 ;;^UTILITY(U,$J,358.3,16955,0)
 ;;=E11.622^^56^674^31
 ;;^UTILITY(U,$J,358.3,16955,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16955,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Ulcer
 ;;^UTILITY(U,$J,358.3,16955,1,4,0)
 ;;=4^E11.622
 ;;^UTILITY(U,$J,358.3,16955,2)
 ;;=^5002657
 ;;^UTILITY(U,$J,358.3,16956,0)
 ;;=E11.628^^56^674^30
 ;;^UTILITY(U,$J,358.3,16956,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16956,1,3,0)
 ;;=3^DM Type 2 w/ Oth Skin Compl
 ;;^UTILITY(U,$J,358.3,16956,1,4,0)
 ;;=4^E11.628
 ;;^UTILITY(U,$J,358.3,16956,2)
 ;;=^5002658
 ;;^UTILITY(U,$J,358.3,16957,0)
 ;;=E11.630^^56^674^33
 ;;^UTILITY(U,$J,358.3,16957,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16957,1,3,0)
 ;;=3^DM Type 2 w/ Periodontal Disease
 ;;^UTILITY(U,$J,358.3,16957,1,4,0)
 ;;=4^E11.630
 ;;^UTILITY(U,$J,358.3,16957,2)
 ;;=^5002659
 ;;^UTILITY(U,$J,358.3,16958,0)
 ;;=E11.638^^56^674^29
 ;;^UTILITY(U,$J,358.3,16958,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16958,1,3,0)
 ;;=3^DM Type 2 w/ Oth Oral Compl
 ;;^UTILITY(U,$J,358.3,16958,1,4,0)
 ;;=4^E11.638
 ;;^UTILITY(U,$J,358.3,16958,2)
 ;;=^5002660
 ;;^UTILITY(U,$J,358.3,16959,0)
 ;;=E11.641^^56^674^20
 ;;^UTILITY(U,$J,358.3,16959,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16959,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/ Coma
 ;;^UTILITY(U,$J,358.3,16959,1,4,0)
 ;;=4^E11.641
 ;;^UTILITY(U,$J,358.3,16959,2)
 ;;=^5002661
 ;;^UTILITY(U,$J,358.3,16960,0)
 ;;=E11.649^^56^674^21
 ;;^UTILITY(U,$J,358.3,16960,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16960,1,3,0)
 ;;=3^DM Type 2 w/ Hypoglycemia w/o Coma
 ;;^UTILITY(U,$J,358.3,16960,1,4,0)
 ;;=4^E11.649
 ;;^UTILITY(U,$J,358.3,16960,2)
 ;;=^5002662
 ;;^UTILITY(U,$J,358.3,16961,0)
 ;;=E11.65^^56^674^17
 ;;^UTILITY(U,$J,358.3,16961,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16961,1,3,0)
 ;;=3^DM Type 2 w/ Hyperglycemia
 ;;^UTILITY(U,$J,358.3,16961,1,4,0)
 ;;=4^E11.65
 ;;^UTILITY(U,$J,358.3,16961,2)
 ;;=^5002663
 ;;^UTILITY(U,$J,358.3,16962,0)
 ;;=E11.69^^56^674^32
 ;;^UTILITY(U,$J,358.3,16962,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16962,1,3,0)
 ;;=3^DM Type 2 w/ Oth Spec Compl
 ;;^UTILITY(U,$J,358.3,16962,1,4,0)
 ;;=4^E11.69
 ;;^UTILITY(U,$J,358.3,16962,2)
 ;;=^5002664
 ;;^UTILITY(U,$J,358.3,16963,0)
 ;;=E11.8^^56^674^34
 ;;^UTILITY(U,$J,358.3,16963,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16963,1,3,0)
 ;;=3^DM Type 2 w/ Unspec Compl
 ;;^UTILITY(U,$J,358.3,16963,1,4,0)
 ;;=4^E11.8
 ;;^UTILITY(U,$J,358.3,16963,2)
 ;;=^5002665
 ;;^UTILITY(U,$J,358.3,16964,0)
 ;;=E11.9^^56^674^35
 ;;^UTILITY(U,$J,358.3,16964,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16964,1,3,0)
 ;;=3^DM Type 2 w/o Complications
 ;;^UTILITY(U,$J,358.3,16964,1,4,0)
 ;;=4^E11.9
 ;;^UTILITY(U,$J,358.3,16964,2)
 ;;=^5002666
 ;;^UTILITY(U,$J,358.3,16965,0)
 ;;=E11.29^^56^674^27
 ;;^UTILITY(U,$J,358.3,16965,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16965,1,3,0)
 ;;=3^DM Type 2 w/ Oth Diab Kidney Compl
 ;;^UTILITY(U,$J,358.3,16965,1,4,0)
 ;;=4^E11.29
 ;;^UTILITY(U,$J,358.3,16965,2)
 ;;=^5002631
 ;;^UTILITY(U,$J,358.3,16966,0)
 ;;=E11.311^^56^674^14
 ;;^UTILITY(U,$J,358.3,16966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16966,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/ Macular Edema
 ;;^UTILITY(U,$J,358.3,16966,1,4,0)
 ;;=4^E11.311
 ;;^UTILITY(U,$J,358.3,16966,2)
 ;;=E11.319^5002632
 ;;^UTILITY(U,$J,358.3,16967,0)
 ;;=E11.319^^56^674^15
 ;;^UTILITY(U,$J,358.3,16967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16967,1,3,0)
 ;;=3^DM Type 2 w/ Diab Rtnop w/o Macular Edema
 ;;^UTILITY(U,$J,358.3,16967,1,4,0)
 ;;=4^E11.319
 ;;^UTILITY(U,$J,358.3,16967,2)
 ;;=^5002633
 ;;^UTILITY(U,$J,358.3,16968,0)
 ;;=E11.3211^^56^674^22
 ;;^UTILITY(U,$J,358.3,16968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16968,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Rt Eye
 ;;^UTILITY(U,$J,358.3,16968,1,4,0)
 ;;=4^E11.3211
 ;;^UTILITY(U,$J,358.3,16968,2)
 ;;=^5138331
 ;;^UTILITY(U,$J,358.3,16969,0)
 ;;=E11.3212^^56^674^23
 ;;^UTILITY(U,$J,358.3,16969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16969,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Lt Eye
 ;;^UTILITY(U,$J,358.3,16969,1,4,0)
 ;;=4^E11.3212
 ;;^UTILITY(U,$J,358.3,16969,2)
 ;;=^5138332
 ;;^UTILITY(U,$J,358.3,16970,0)
 ;;=E11.3213^^56^674^24
 ;;^UTILITY(U,$J,358.3,16970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16970,1,3,0)
 ;;=3^DM Type 2 w/ Mild Nonp Rtnop w/ Macular Edema,Bilat
 ;;^UTILITY(U,$J,358.3,16970,1,4,0)
 ;;=4^E11.3213
 ;;^UTILITY(U,$J,358.3,16970,2)
 ;;=^5138333
 ;;^UTILITY(U,$J,358.3,16971,0)
 ;;=E11.40^^56^674^10
 ;;^UTILITY(U,$J,358.3,16971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16971,1,3,0)
 ;;=3^DM Type 2 w/ Diab Neuropathy,Unspec
 ;;^UTILITY(U,$J,358.3,16971,1,4,0)
 ;;=4^E11.40
 ;;^UTILITY(U,$J,358.3,16971,2)
 ;;=^5002644
 ;;^UTILITY(U,$J,358.3,16972,0)
 ;;=E11.51^^56^674^12
 ;;^UTILITY(U,$J,358.3,16972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16972,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/o Gangrene
 ;;^UTILITY(U,$J,358.3,16972,1,4,0)
 ;;=4^E11.51
 ;;^UTILITY(U,$J,358.3,16972,2)
 ;;=^5002650
 ;;^UTILITY(U,$J,358.3,16973,0)
 ;;=E11.52^^56^674^11
 ;;^UTILITY(U,$J,358.3,16973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16973,1,3,0)
 ;;=3^DM Type 2 w/ Diab Periph Angiopathy w/ Gangrene
 ;;^UTILITY(U,$J,358.3,16973,1,4,0)
 ;;=4^E11.52
 ;;^UTILITY(U,$J,358.3,16973,2)
 ;;=^5002651
 ;;^UTILITY(U,$J,358.3,16974,0)
 ;;=E11.620^^56^674^5
 ;;^UTILITY(U,$J,358.3,16974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16974,1,3,0)
 ;;=3^DM Type 2 w/ Diab Dermatitis
 ;;^UTILITY(U,$J,358.3,16974,1,4,0)
 ;;=4^E11.620
 ;;^UTILITY(U,$J,358.3,16974,2)
 ;;=^5002655
 ;;^UTILITY(U,$J,358.3,16975,0)
 ;;=E11.36^^56^674^4
 ;;^UTILITY(U,$J,358.3,16975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16975,1,3,0)
 ;;=3^DM Type 2 w/ Diab Cataract
 ;;^UTILITY(U,$J,358.3,16975,1,4,0)
 ;;=4^E11.36
 ;;^UTILITY(U,$J,358.3,16975,2)
 ;;=^5002642
 ;;^UTILITY(U,$J,358.3,16976,0)
 ;;=I10.^^56^675^1
 ;;^UTILITY(U,$J,358.3,16976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16976,1,3,0)
 ;;=3^Essential/Primary Hypertension
 ;;^UTILITY(U,$J,358.3,16976,1,4,0)
 ;;=4^I10.
 ;;^UTILITY(U,$J,358.3,16976,2)
 ;;=^5007062
 ;;^UTILITY(U,$J,358.3,16977,0)
 ;;=I11.0^^56^675^12
 ;;^UTILITY(U,$J,358.3,16977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16977,1,3,0)
 ;;=3^Hypertensive Heart Disease w/ Heart Failure
 ;;^UTILITY(U,$J,358.3,16977,1,4,0)
 ;;=4^I11.0
 ;;^UTILITY(U,$J,358.3,16977,2)
 ;;=^5007063
 ;;^UTILITY(U,$J,358.3,16978,0)
 ;;=I11.9^^56^675^13
 ;;^UTILITY(U,$J,358.3,16978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16978,1,3,0)
 ;;=3^Hypertensive Heart Disease w/o Heart Failure
 ;;^UTILITY(U,$J,358.3,16978,1,4,0)
 ;;=4^I11.9
 ;;^UTILITY(U,$J,358.3,16978,2)
 ;;=^5007064
 ;;^UTILITY(U,$J,358.3,16979,0)
 ;;=I12.0^^56^675^5
 ;;^UTILITY(U,$J,358.3,16979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16979,1,3,0)
 ;;=3^Hypertensive CKD w/ Stage 5 CKD or ESRD
 ;;^UTILITY(U,$J,358.3,16979,1,4,0)
 ;;=4^I12.0
 ;;^UTILITY(U,$J,358.3,16979,2)
 ;;=^5007065
 ;;^UTILITY(U,$J,358.3,16980,0)
 ;;=I12.9^^56^675^4
 ;;^UTILITY(U,$J,358.3,16980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16980,1,3,0)
 ;;=3^Hypertensive CKD w/ Stage 1-4 CKD
 ;;^UTILITY(U,$J,358.3,16980,1,4,0)
 ;;=4^I12.9
 ;;^UTILITY(U,$J,358.3,16980,2)
 ;;=^5007066
 ;;^UTILITY(U,$J,358.3,16981,0)
 ;;=I13.0^^56^675^8
 ;;^UTILITY(U,$J,358.3,16981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16981,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 1-4 CKD
 ;;^UTILITY(U,$J,358.3,16981,1,4,0)
 ;;=4^I13.0
 ;;^UTILITY(U,$J,358.3,16981,2)
 ;;=^5007067
 ;;^UTILITY(U,$J,358.3,16982,0)
 ;;=I13.10^^56^675^10
 ;;^UTILITY(U,$J,358.3,16982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16982,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 1-4 CKD
 ;;^UTILITY(U,$J,358.3,16982,1,4,0)
 ;;=4^I13.10
 ;;^UTILITY(U,$J,358.3,16982,2)
 ;;=^5007068
 ;;^UTILITY(U,$J,358.3,16983,0)
 ;;=I13.11^^56^675^11
 ;;^UTILITY(U,$J,358.3,16983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16983,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/o Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,16983,1,4,0)
 ;;=4^I13.11
 ;;^UTILITY(U,$J,358.3,16983,2)
 ;;=^5007069
 ;;^UTILITY(U,$J,358.3,16984,0)
 ;;=I13.2^^56^675^9
 ;;^UTILITY(U,$J,358.3,16984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16984,1,3,0)
 ;;=3^Hypertensive HRT & CKD w/ Hrt Fail & Stg 5 CKD/ESRD
 ;;^UTILITY(U,$J,358.3,16984,1,4,0)
 ;;=4^I13.2
 ;;^UTILITY(U,$J,358.3,16984,2)
 ;;=^5007070
 ;;^UTILITY(U,$J,358.3,16985,0)
 ;;=I15.0^^56^675^15
 ;;^UTILITY(U,$J,358.3,16985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16985,1,3,0)
 ;;=3^Renovascular Hypertension
 ;;^UTILITY(U,$J,358.3,16985,1,4,0)
 ;;=4^I15.0
 ;;^UTILITY(U,$J,358.3,16985,2)
 ;;=^5007071
 ;;^UTILITY(U,$J,358.3,16986,0)
 ;;=I15.1^^56^675^3
 ;;^UTILITY(U,$J,358.3,16986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16986,1,3,0)
 ;;=3^Hypertension Secondary to Oth Renal Disorders
 ;;^UTILITY(U,$J,358.3,16986,1,4,0)
 ;;=4^I15.1
 ;;^UTILITY(U,$J,358.3,16986,2)
 ;;=^5007072
 ;;^UTILITY(U,$J,358.3,16987,0)
 ;;=I15.2^^56^675^2
 ;;^UTILITY(U,$J,358.3,16987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16987,1,3,0)
 ;;=3^Hypertension Secondary to Endocrine Disorders
 ;;^UTILITY(U,$J,358.3,16987,1,4,0)
 ;;=4^I15.2
 ;;^UTILITY(U,$J,358.3,16987,2)
 ;;=^5007073
 ;;^UTILITY(U,$J,358.3,16988,0)
 ;;=I15.8^^56^675^16
 ;;^UTILITY(U,$J,358.3,16988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16988,1,3,0)
 ;;=3^Secondary Hypertension,Oth
 ;;^UTILITY(U,$J,358.3,16988,1,4,0)
 ;;=4^I15.8
 ;;^UTILITY(U,$J,358.3,16988,2)
 ;;=^5007074
 ;;^UTILITY(U,$J,358.3,16989,0)
 ;;=I15.9^^56^675^17
 ;;^UTILITY(U,$J,358.3,16989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16989,1,3,0)
 ;;=3^Secondary Hypertension,Unspec
 ;;^UTILITY(U,$J,358.3,16989,1,4,0)
 ;;=4^I15.9
 ;;^UTILITY(U,$J,358.3,16989,2)
 ;;=^5007075
 ;;^UTILITY(U,$J,358.3,16990,0)
 ;;=I16.0^^56^675^14
 ;;^UTILITY(U,$J,358.3,16990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16990,1,3,0)
 ;;=3^Hypertensive Urgency
 ;;^UTILITY(U,$J,358.3,16990,1,4,0)
 ;;=4^I16.0
 ;;^UTILITY(U,$J,358.3,16990,2)
 ;;=^8133013
 ;;^UTILITY(U,$J,358.3,16991,0)
 ;;=I16.1^^56^675^7
 ;;^UTILITY(U,$J,358.3,16991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16991,1,3,0)
 ;;=3^Hypertensive Emergency
 ;;^UTILITY(U,$J,358.3,16991,1,4,0)
 ;;=4^I16.1
 ;;^UTILITY(U,$J,358.3,16991,2)
 ;;=^8204721
 ;;^UTILITY(U,$J,358.3,16992,0)
 ;;=I16.9^^56^675^6
 ;;^UTILITY(U,$J,358.3,16992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16992,1,3,0)
 ;;=3^Hypertensive Crisis,Unspec
 ;;^UTILITY(U,$J,358.3,16992,1,4,0)
 ;;=4^I16.9
 ;;^UTILITY(U,$J,358.3,16992,2)
 ;;=^5138600
 ;;^UTILITY(U,$J,358.3,16993,0)
 ;;=A07.0^^56^676^5
 ;;^UTILITY(U,$J,358.3,16993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16993,1,3,0)
 ;;=3^Balantidiasis
 ;;^UTILITY(U,$J,358.3,16993,1,4,0)
 ;;=4^A07.0
 ;;^UTILITY(U,$J,358.3,16993,2)
 ;;=^12533
 ;;^UTILITY(U,$J,358.3,16994,0)
 ;;=A07.1^^56^676^9
 ;;^UTILITY(U,$J,358.3,16994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16994,1,3,0)
 ;;=3^Giardiasis [lambliasis]
 ;;^UTILITY(U,$J,358.3,16994,1,4,0)
 ;;=4^A07.1
 ;;^UTILITY(U,$J,358.3,16994,2)
 ;;=^5000049
 ;;^UTILITY(U,$J,358.3,16995,0)
 ;;=A07.2^^56^676^7
 ;;^UTILITY(U,$J,358.3,16995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16995,1,3,0)
 ;;=3^Cryptosporidiosis
 ;;^UTILITY(U,$J,358.3,16995,1,4,0)
 ;;=4^A07.2
 ;;^UTILITY(U,$J,358.3,16995,2)
 ;;=^29629
 ;;^UTILITY(U,$J,358.3,16996,0)
 ;;=A07.3^^56^676^12
 ;;^UTILITY(U,$J,358.3,16996,1,0)
 ;;=^358.31IA^4^2
